2.50
Hdl Handle:
http://hdl.handle.net/10033/604382
Title:
Single-domain antibodies for biomedical applications.
Authors:
Krah, Simon; Schröter, Christian; Zielonka, Stefan; Empting, Martin ( 0000-0002-0503-5830 ) ; Valldorf, Bernhard; Kolmar, Harald
Abstract:
Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.
Affiliation:
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany.
Citation:
Single-domain antibodies for biomedical applications. 2016, 38 (1):21-8 Immunopharmacol Immunotoxicol
Journal:
Immunopharmacology and immunotoxicology
Issue Date:
Feb-2016
URI:
http://hdl.handle.net/10033/604382
DOI:
10.3109/08923973.2015.1102934
PubMed ID:
26551147
Type:
Article
Language:
en
ISSN:
1532-2513
Appears in Collections:
publications of the department drug design and optimization (HIPS]DDOP)

Full metadata record

DC FieldValue Language
dc.contributor.authorKrah, Simonen
dc.contributor.authorSchröter, Christianen
dc.contributor.authorZielonka, Stefanen
dc.contributor.authorEmpting, Martinen
dc.contributor.authorValldorf, Bernharden
dc.contributor.authorKolmar, Haralden
dc.date.accessioned2016-04-04T14:22:16Zen
dc.date.available2016-04-04T14:22:16Zen
dc.date.issued2016-02en
dc.identifier.citationSingle-domain antibodies for biomedical applications. 2016, 38 (1):21-8 Immunopharmacol Immunotoxicolen
dc.identifier.issn1532-2513en
dc.identifier.pmid26551147en
dc.identifier.doi10.3109/08923973.2015.1102934en
dc.identifier.urihttp://hdl.handle.net/10033/604382en
dc.description.abstractSingle-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.en
dc.language.isoenen
dc.titleSingle-domain antibodies for biomedical applications.en
dc.typeArticleen
dc.contributor.departmentHelmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany.en
dc.identifier.journalImmunopharmacology and immunotoxicologyen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.